{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:47Z","timestamp":1790375987928,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":106,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811072291","type":"print"},{"value":"9789811072307","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-10-7230-7_21","type":"book-chapter","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T10:29:29Z","timestamp":1528799369000},"page":"459-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["EBV in T-\/NK-Cell Tumorigenesis"],"prefix":"10.1007","author":[{"given":"Hiroshi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"21_CR1","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1128\/JVI.61.10.3306-3309.1987","volume":"61","author":"C Alfieri","year":"1987","unstructured":"Alfieri C, Joncas JH (1987) Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. J Virol 61:3306\u20133309","journal-title":"J Virol"},{"key":"21_CR2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V85.3.744.bloodjournal853744","volume":"85","author":"I Anagnostopoulos","year":"1995","unstructured":"Anagnostopoulos I, Hummel M, Kreschel C, Stein H (1995) Morphology, immunophenotype, and distribution of latently and\/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744\u2013750","journal-title":"Blood"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12185-008-0021-7","volume":"87","author":"K Aozasa","year":"2008","unstructured":"Aozasa K, Takakuwa T, Hongyo T, Yang WI (2008) Nasal NK\/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol 87:110\u2013117","journal-title":"Int J Hematol"},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0602-594","volume":"8","author":"CM Borza","year":"2002","unstructured":"Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8:594\u2013599","journal-title":"Nat Med"},{"key":"21_CR5","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Jaffe ES, Ralfkiaer E, Ko YH (2008a) Aggressive NK-cell leukaemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. WHO Press, Lyon"},{"key":"21_CR6","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Quintanilla-Martinez L, Ferry JA, Peh S-C (2008b) Extranodal NK\/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. WHO Press, Lyon","edition":"4"},{"key":"21_CR7","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1128\/JVI.67.10.6303-6308.1993","volume":"67","author":"CL Chen","year":"1993","unstructured":"Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N (1993) Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 67:6303\u20136308","journal-title":"J Virol"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343:481\u2013492","journal-title":"N Engl J Med"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","volume":"20","author":"JI Cohen","year":"2009","unstructured":"Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES (2009) Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8\u20139 September 2008. Ann Oncol 20:1472\u20131482","journal-title":"Ann Oncol"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE (2011) Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 117:5835\u20135849","journal-title":"Blood"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1128\/JVI.03001-14","volume":"89","author":"CB Coleman","year":"2015","unstructured":"Coleman CB, Wohlford EM, Smith NA, King CA, Ritchie JA, Baresel PC, Kimura H, Rochford R (2015) Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. J Virol 89:2301\u20132312","journal-title":"J Virol"},{"key":"21_CR12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/gcc.22348","volume":"55","author":"A Dobashi","year":"2016","unstructured":"Dobashi A, Tsuyama N, Asaka R, Togashi Y, Ueda K, Sakata S, Baba S, Sakamoto K, Hatake K, Takeuchi K (2016) Frequent BCOR aberrations in extranodal NK\/T-Cell lymphoma, nasal type. Genes Chromosomes Cancer 55:460\u2013471","journal-title":"Genes Chromosomes Cancer"},{"key":"21_CR13","first-page":"754","volume":"11","author":"KS Elenitoba-Johnson","year":"1998","unstructured":"Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, Krenacs L, Kingma DW, Raffeld M, Jaffe ES (1998) Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte\/natural killer cell lymphomas from Mexico. Mod Pathol 11:754\u2013761","journal-title":"Mod Pathol"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.mehy.2004.03.012","volume":"63","author":"R Endo","year":"2004","unstructured":"Endo R, Yoshioka M, Ebihara T, Ishiguro N, Kikuta H, Kobayashi K (2004) Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection. Med Hypotheses 63:582\u2013587","journal-title":"Med Hypotheses"},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 1:702\u2013703","journal-title":"Lancet"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.146.3.865","volume":"146","author":"E Fischer","year":"1991","unstructured":"Fischer E, Delibrias C, Kazatchkine MD (1991) Expression of CR2 (the C3dg\/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146:865\u2013869","journal-title":"J Immunol"},{"key":"21_CR17","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/intimm\/11.11.1841","volume":"11","author":"EM Fischer","year":"1999","unstructured":"Fischer EM, Mouhoub A, Maillet F, Fremeaux-Bacchi V, Krief C, Gould H, Berrih-Aknin S, Kazatchkine MD (1999) Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes. Int Immunol 11:1841\u20131849","journal-title":"Int Immunol"},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2010-06-292268","volume":"116","author":"CP Fox","year":"2010","unstructured":"Fox CP, Haigh TA, Taylor GS, Long HM, Lee SP, Shannon-Lowe C, O'connor S, Bollard CM, Iqbal J, Chan WC, Rickinson AB, Bell AI, Rowe M (2010) A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy. Blood 116:3695\u20133704","journal-title":"Blood"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1128\/JVI.69.6.3900-3903.1995","volume":"69","author":"S Fujiwara","year":"1995","unstructured":"Fujiwara S, Ono Y (1995) Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker. J Virol 69:3900\u20133903","journal-title":"J Virol"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/ped.12314","volume":"56","author":"S Fujiwara","year":"2014","unstructured":"Fujiwara S, Kimura H, Imadome K, Arai A, Kodama E, Morio T, Shimizu N, Wakiguchi H (2014) Current research on chronic active Epstein-Barr virus infection in Japan. Pediatr Int 56:159\u2013166","journal-title":"Pediatr Int"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1086\/587671","volume":"46","author":"K Gotoh","year":"2008","unstructured":"Gotoh K, Ito Y, Shibata-Watanabe Y, Kawada J, Takahashi Y, Yagasaki H, Kojima S, Nishiyama Y, Kimura H (2008) Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis 46:1525\u20131534","journal-title":"Clin Infect Dis"},{"key":"21_CR22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11899-015-0292-z","volume":"10","author":"AA Gru","year":"2015","unstructured":"Gru AA, Haverkos BH, Freud AG, Hastings J, Nowacki NB, Barrionuevo C, Vigil CE, Rochford R, Natkunam Y, Baiocchi RA, Porcu P (2015) The Epstein-Barr virus (EBV) in T cell and NK cell lymphomas: time for a reassessment. Curr Hematol Malig Rep 10:456\u2013467","journal-title":"Curr Hematol Malig Rep"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2014.12.030","volume":"42","author":"E Grywalska","year":"2015","unstructured":"Grywalska E, Rolinski J (2015) Epstein-Barr virus-associated lymphomas. Semin Oncol 42:291\u2013303","journal-title":"Semin Oncol"},{"issue":"6","key":"21_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/pin.12166","volume":"64","author":"Y Guo","year":"2014","unstructured":"Guo Y, Arakawa F, Miyoshi H, Niino D, Kawano R, Ohshima K (2014) Activated janus kinase 3 expression not by activating mutations identified in natural killer\/T-cell lymphoma. Pathol Int 64(6):263","journal-title":"Pathol Int"},{"key":"21_CR25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","volume":"335","author":"Y Harabuchi","year":"1990","unstructured":"Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T (1990) Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128\u2013130","journal-title":"Lancet"},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1182\/blood.V79.8.2116.2116","volume":"79","author":"DN Hart","year":"1992","unstructured":"Hart DN, Baker BW, Inglis MJ, Nimmo JC, Starling GC, Deacon E, Rowe M, Beard ME (1992) Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 79:2116\u20132123","journal-title":"Blood"},{"key":"21_CR27","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.4049\/jimmunol.171.10.5215","volume":"171","author":"B He","year":"2003","unstructured":"He B, Raab-Traub N, Casali P, Cerutti A (2003) EBV-encoded latent membrane protein 1 cooperates with BAFF\/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J Immunol 171:5215\u20135224","journal-title":"J Immunol"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/jnci\/94.23.1780","volume":"94","author":"A Hildesheim","year":"2002","unstructured":"Hildesheim A, Apple RJ, Chen CJ, Wang SS, Cheng YJ, Klitz W, Mack SJ, Chen IH, Hsu MM, Yang CS, Brinton LA, Levine PH, Erlich HA (2002) Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 94:1780\u20131789","journal-title":"J Natl Cancer Inst"},{"key":"21_CR29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.immuni.2004.05.011","volume":"20","author":"T Honjo","year":"2004","unstructured":"Honjo T, Muramatsu M, Fagarasan S (2004) AID: how does it aid antibody diversity? Immunity 20:659\u2013668","journal-title":"Immunity"},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","volume":"115","author":"Y Huang","year":"2010","unstructured":"Huang Y, De Reynies A, De Leval L, Ghazi B, Martin-Garcia N, Travert M, Bosq J, Briere J, Petit B, Thomas E, Coppo P, Marafioti T, Emile JF, Delfau-Larue MH, Schmitt C, Gaulard P (2010) Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type. Blood 115:1226\u20131237","journal-title":"Blood"},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/modpathol.3800369","volume":"18","author":"SD Hudnall","year":"2005","unstructured":"Hudnall SD, Ge Y, Wei L, Yang NP, Wang HQ, Chen T (2005) Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18:519\u2013527","journal-title":"Mod Pathol"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.00445-07","volume":"81","author":"LM Hutt-Fletcher","year":"2007","unstructured":"Hutt-Fletcher LM (2007) Epstein-Barr virus entry. J Virol 81:7825\u20137832","journal-title":"J Virol"},{"key":"21_CR33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/cimm.1993.1147","volume":"149","author":"Y Ichigi","year":"1993","unstructured":"Ichigi Y, Naitoh K, Tokushima M, Haraoka S, Tagoh H, Kimoto M, Muraguchi A (1993) Generation of cells with morphological and antigenic properties of microglia from cloned EBV-transformed lymphoid progenitor cells derived from human fetal liver. Cell Immunol 149:193\u2013207","journal-title":"Cell Immunol"},{"key":"21_CR34","doi-asserted-by":"crossref","first-page":"e1002326","DOI":"10.1371\/journal.ppat.1002326","volume":"7","author":"K Imadome","year":"2011","unstructured":"Imadome K, Yajima M, Arai A, Nakazawa A, Kawano F, Ichikawa S, Shimizu N, Yamamoto N, Morio T, Ohga S, Nakamura H, Ito M, Miura O, Komano J, Fujiwara S (2011) Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells. PLoS Pathog 7:e1002326","journal-title":"PLoS Pathog"},{"key":"21_CR35","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1182\/blood.V87.4.1446.bloodjournal8741446","volume":"87","author":"S Imai","year":"1996","unstructured":"Imai S, Sugiura M, Oikawa O, Koizumi S, Hirao M, Kimura H, Hayashibara H, Terai N, Tsutsumi H, Oda T, Chiba S, Osato T (1996) Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 87:1446\u20131457","journal-title":"Blood"},{"key":"21_CR36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","volume":"23","author":"J Iqbal","year":"2009","unstructured":"Iqbal J, Kucuk C, Deleeuw RJ, Srivastava G, Tam W, Geng H, Klinkebiel D, Christman JK, Patel K, Cao K, Shen L, Dybkaer K, Tsui IF, Ali H, Shimizu N, Au WY, Lam WL, Chan WC (2009) Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 23:1139\u20131151","journal-title":"Leukemia"},{"key":"21_CR37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1096-8652(199704)54:4<276::AID-AJH3>3.0.CO;2-S","volume":"54","author":"S Ishihara","year":"1997","unstructured":"Ishihara S, Okada S, Wakiguchi H, Kurashige T, Hirai K, Kawa-Ha K (1997) Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol 54:276\u2013281","journal-title":"Am J Hematol"},{"key":"21_CR38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/carcin\/bgq222","volume":"32","author":"C Ishikawa","year":"2011","unstructured":"Ishikawa C, Nakachi S, Senba M, Sugai M, Mori N (2011) Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis. Carcinogenesis 32:110\u2013119","journal-title":"Carcinogenesis"},{"key":"21_CR39","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1158\/0008-5472.CAN-03-1562","volume":"64","author":"Y Isobe","year":"2004","unstructured":"Isobe Y, Sugimoto K, Yang L, Tamayose K, Egashira M, Kaneko T, Takada K, Oshimi K (2004) Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells. Cancer Res 64:2167\u20132174","journal-title":"Cancer Res"},{"key":"21_CR40","first-page":"1549","volume":"13","author":"O Itakura","year":"1996","unstructured":"Itakura O, Yamada S, Narita M, Kikuta H (1996) High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population. Oncogene 13:1549\u20131553","journal-title":"Oncogene"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/pbc.24319","volume":"60","author":"Y Ito","year":"2013","unstructured":"Ito Y, Kawamura Y, Iwata S, Kawada J, Yoshikawa T, Kimura H (2013a) Demonstration of type II latency in T lymphocytes of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 60:326\u2013328","journal-title":"Pediatr Blood Cancer"},{"key":"21_CR42","unstructured":"Ito Y, Suzuki R, Torii Y, Kawa K, Kikuta A, Kojima S, Kimura H (2013b) HLA-A*26 and HLA-B*52 are associated with a risk of developing EBV-associated T\/NK lymphoproliferative disease. Blood e-Letter, bloodjournal_el; 8085"},{"key":"21_CR43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1099\/vir.0.013482-0","volume":"91","author":"S Iwata","year":"2010","unstructured":"Iwata S, Wada K, Tobita S, Gotoh K, Ito Y, Demachi-Okamura A, Shimizu N, Nishiyama Y, Kimura H (2010) Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. J Gen Virol 91:42\u201350","journal-title":"J Gen Virol"},{"key":"21_CR44","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2133.1999.02777.x","volume":"140","author":"K Iwatsuki","year":"1999","unstructured":"Iwatsuki K, Xu Z, Takata M, Iguchi M, Ohtsuka M, Akiba H, Mitsuhashi Y, Takenoshita H, Sugiuchi R, Tagami H, Kaneko F (1999) The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol 140:715\u2013721","journal-title":"Br J Dermatol"},{"key":"21_CR45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang L, Gu ZH, Yan ZX, Zhao X, Xie YY, Zhang ZG, Pan CM, Hu Y, Cai CP, Dong Y, Huang JY, Wang L, Shen Y, Meng G, Zhou JF, Hu JD, Wang JF, Liu YH, Yang LH, Zhang F, Wang JM, Wang Z, Peng ZG, Chen FY, Sun ZM, Ding H, Shi JM, Hou J, Yan JS, Shi JY, Xu L, Li Y, Lu J, Zheng Z, Xue W, Zhao WL, Chen Z, Chen SJ (2015) Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat Genet 47:1061\u20131066","journal-title":"Nat Genet"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198803243181203","volume":"318","author":"J Jones","year":"1988","unstructured":"Jones J, Shurin S, Abramowsky C, Tubbs R, Sciotto C, Wahl R, Sands J, Gottman D, Katz B, Sklar J (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733\u2013741","journal-title":"N Engl J Med"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1158\/1078-0432.CCR-11-2395","volume":"18","author":"N Kanemitsu","year":"2012","unstructured":"Kanemitsu N, Isobe Y, Masuda A, Momose S, Higashi M, Tamaru JI, Sugimoto K, Komatsu N (2012) Expression of Epstein-Barr virus-encoded proteins in extranodal NK\/T-cell lymphoma, nasal type (ENKL): differences in biological and clinical behaviors of LMP1-positive and -negative ENKL. Clin Cancer Res 18:2164\u20132172","journal-title":"Clin Cancer Res"},{"key":"21_CR48","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","volume":"118","author":"K Karube","year":"2011","unstructured":"Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y, Shimizu N, Ko YH, Morishima Y, Ohshima K, Nakamura S, Seto M (2011) Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 118:3195\u20133204","journal-title":"Blood"},{"key":"21_CR49","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","volume":"98","author":"Y Kasahara","year":"2001","unstructured":"Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S (2001) Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 98:1882\u20131888","journal-title":"Blood"},{"key":"21_CR50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bmt.2010.122","volume":"46","author":"K Kawa","year":"2011","unstructured":"Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, Kimoto T, Yamada K, Tokimasa S, Yasui M, Inoue M (2011) Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant 46:77\u201383","journal-title":"Bone Marrow Transplant"},{"key":"21_CR51","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI116721","volume":"92","author":"H Kawaguchi","year":"1993","unstructured":"Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai M, Kobayashi N, Et A (1993) Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 92:1444\u20131450","journal-title":"J Clin Invest"},{"key":"21_CR52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI114168","volume":"84","author":"K Kawa-Ha","year":"1989","unstructured":"Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, Tawa A, Hirai K (1989) CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84:51\u201355","journal-title":"J Clin Invest"},{"key":"21_CR53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/333455a0","volume":"333","author":"H Kikuta","year":"1988","unstructured":"Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, Et A (1988) Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455\u2013457","journal-title":"Nature"},{"key":"21_CR54","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3109\/10428194.2013.769218","volume":"54","author":"JH Kim","year":"2013","unstructured":"Kim JH, Kim WS, Park C (2013) Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma. Leuk Lymphoma 54:2035\u20132040","journal-title":"Leuk Lymphoma"},{"key":"21_CR55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/rmv.505","volume":"16","author":"H Kimura","year":"2006","unstructured":"Kimura H (2006) Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 16:251\u2013261","journal-title":"Rev Med Virol"},{"key":"21_CR56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/367988","volume":"187","author":"H Kimura","year":"2003","unstructured":"Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, Tsuchiya S, Yachie A, Imashuku S, Kawa K, Wakiguchi H (2003) Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187:527\u2013533","journal-title":"J Infect Dis"},{"key":"21_CR57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/427239","volume":"191","author":"H Kimura","year":"2005","unstructured":"Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, Shibata Y, Kojima S, Nagasaka T, Kuzushima K, Morishima T (2005) Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 191:531\u2013539","journal-title":"J Infect Dis"},{"key":"21_CR58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S (2012) EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 119:673\u2013686","journal-title":"Blood"},{"key":"21_CR59","first-page":"169","volume":"75","author":"H Kimura","year":"2013","unstructured":"Kimura H, Kawada J, Ito Y (2013) Epstein-Barr virus-associated lymphoid malignancies: the expanding spectrum of hematopoietic neoplasms. Nagoya J Med Sci 75:169\u2013179","journal-title":"Nagoya J Med Sci"},{"key":"21_CR60","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/10428194.2013.819577","volume":"55","author":"H Kimura","year":"2014","unstructured":"Kimura H, Karube K, Ito Y, Hirano K, Suzuki M, Iwata S, Seto M (2014) Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan. Leuk Lymphoma 55:962\u2013963","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"21_CR61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","volume":"2","author":"GC Koo","year":"2012","unstructured":"Koo GC, Tan SY, Tang T, Poon SL, Allen GE, Tan L, Chong SC, Ong WS, Tay K, Tao M, Quek R, Loong S, Yeoh KW, Yap SP, Lee KA, Lim LC, Tan D, Goh C, Cutcutache I, Yu W, Ng CC, Rajasegaran V, Heng HL, Gan A, Ong CK, Rozen S, Tan P, Teh BT, Lim ST (2012) Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma. Cancer Discov 2(7):591","journal-title":"Cancer Discov"},{"key":"21_CR62","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(16)30148-6","volume":"17","author":"Z Li","year":"2016","unstructured":"Li Z, Xia Y, Feng LN, Chen JR, Li HM, Cui J, Cai QQ, Sim KS, Nairismagi ML, Laurensia Y, Meah WY, Liu WS, Guo YM, Chen LZ, Feng QS, Pang CP, Chen LJ, Chew SH, Ebstein RP, Foo JN, Liu J, Ha J, Khoo LP, Chin ST, Zeng YX, Aung T, Chowbay B, Diong CP, Zhang F, Liu YH, Tang T, Tao M, Quek R, Mohamad F, Tan SY, Teh BT, Ng SB, Chng WJ, Ong CK, Okada Y, Raychaudhuri S, Lim ST, Tan W, Peng RJ, Khor CC, Bei JX (2016) Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study. Lancet Oncol 17:1240\u20131247","journal-title":"Lancet Oncol"},{"key":"21_CR63","doi-asserted-by":"crossref","first-page":"14121","DOI":"10.1038\/ncomms14121","volume":"8","author":"YY Li","year":"2017","unstructured":"Li YY, Chung GT, Lui VW, To KF, Ma BB, Chow C, Woo JK, Yip KY, Seo J, Hui EP, Mak MK, Rusan M, Chau NG, Or YY, Law MH, Law PP, Liu ZW, Ngan HL, Hau PM, Verhoeft KR, Poon PH, Yoo SK, Shin JY, Lee SD, Lun SW, Jia L, Chan AW, Chan JY, Lai PB, Fung CY, Hung ST, Wang L, Chang AM, Chiosea SI, Hedberg ML, Tsao SW, Van Hasselt AC, Chan AT, Grandis JR, Hammerman PS, Lo KW (2017) Exome and genome sequencing of nasopharynx cancer identifies NF-kappaB pathway activating mutations. Nat Commun 8:14121","journal-title":"Nat Commun"},{"key":"21_CR64","volume-title":"Fields virology","author":"R Longnecker","year":"2013","unstructured":"Longnecker R, Kieff E, Cohen JI (2013) Epstein-Barr virus. In: Knipe DM, Howley PM (eds) Fields virology, 6th edn. Lippincott Williams & Willkins, Philadelphia","edition":"6"},{"key":"21_CR65","first-page":"129","volume":"47","author":"E Louie","year":"1977","unstructured":"Louie E, Henderson BE, Buell P, Jing JS, Menck HR, Pike MC (1977) Selected observations on the epidemiology of pharyngeal cancers. Natl Cancer Inst Monogr 47:129\u2013133","journal-title":"Natl Cancer Inst Monogr"},{"key":"21_CR66","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1684\/ejd.2011.1433","volume":"21","author":"M Nakamura","year":"2011","unstructured":"Nakamura M, Iwata S, Kimura H, Tokura Y (2011a) Elevated expression of activation-induced cytidine deaminase in T and NK cells from patients with chronic active Epstein-Barr virus infection. Eur J Dermatol 21:780\u2013782","journal-title":"Eur J Dermatol"},{"key":"21_CR67","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2133.2011.10342.x","volume":"165","author":"M Nakamura","year":"2011","unstructured":"Nakamura M, Sugita K, Sawada Y, Yoshiki R, Hino R, Tokura Y (2011b) High levels of activation-induced cytidine deaminase expression in adult T-cell leukaemia\/lymphoma. Br J Dermatol 165:437\u2013439","journal-title":"Br J Dermatol"},{"key":"21_CR68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jmv.24633","volume":"89","author":"M Neves","year":"2017","unstructured":"Neves M, Marinho-Dias J, Ribeiro J, Sousa H (2017) Epstein-Barr virus strains and variations: geographic or disease-specific variants? J Med Virol 89:373\u2013387","journal-title":"J Med Virol"},{"key":"21_CR69","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","volume":"110","author":"M Niens","year":"2007","unstructured":"Niens M, Jarrett RF, Hepkema B, Nolte IM, Diepstra A, Platteel M, Kouprie N, Delury CP, Gallagher A, Visser L, Poppema S, Te Meerman GJ, Van Den Berg A (2007) HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. Blood 110:3310\u20133315","journal-title":"Blood"},{"key":"21_CR70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcv.2011.01.014","volume":"51","author":"S Ohga","year":"2011","unstructured":"Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T (2011) Clonal origin of Epstein-Barr virus (EBV)-infected T\/NK-cell subpopulations in EBV-positive T\/NK-cell lymphoproliferative disorders of childhood. J Clin Virol 51:31\u201337","journal-title":"J Clin Virol"},{"key":"21_CR71","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/(SICI)1097-0215(19970611)71:6<943::AID-IJC5>3.0.CO;2-Y","volume":"71","author":"K Ohshima","year":"1997","unstructured":"Ohshima K, Suzumiya J, Ohga S, Ohgami A, Kikuchi M (1997a) Integrated Epstein-Barr virus (EBV) and chromosomal abnormality in chronic active EBV infection. Int J Cancer 71:943\u2013947","journal-title":"Int J Cancer"},{"key":"21_CR72","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.1997.2880887.x","volume":"31","author":"K Ohshima","year":"1997","unstructured":"Ohshima K, Suzumiya J, Shimazaki K, Kato A, Tanaka T, Kanda M, Kikuchi M (1997b) Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology 31:444\u2013450","journal-title":"Histopathology"},{"key":"21_CR73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1440-1827.1999.00816.x","volume":"49","author":"K Ohshima","year":"1999","unstructured":"Ohshima K, Suzumiya J, Sugihara M, Nagafuchi S, Ohga S, Kikuchi M (1999) CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes: a possible mechanism of immune evasion in chronic active EBV infection. Pathol Int 49:9\u201313","journal-title":"Pathol Int"},{"key":"21_CR74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","volume":"80","author":"M Okano","year":"2005","unstructured":"Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S (2005) Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 80:64\u201369","journal-title":"Am J Hematol"},{"key":"21_CR75","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.20030275","volume":"197","author":"IM Okazaki","year":"2003","unstructured":"Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, Honjo T (2003) Constitutive expression of AID leads to tumorigenesis. J Exp Med 197:1173\u20131181","journal-title":"J Exp Med"},{"key":"21_CR76","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(87)92700-0","volume":"1","author":"T Osato","year":"1987","unstructured":"Osato T, Mizuno F, Imai S, Aya T, Koizumi S, Kinoshita T, Tokuda H, Ito Y, Hirai N, Hirota M et al (1987) African Burkitt\u2019s lymphoma and an Epstein-Barr virus-enhancing plant Euphorbia tirucalli. Lancet 1:1257\u20131258","journal-title":"Lancet"},{"key":"21_CR77","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.151.1.92","volume":"151","author":"ER Panzer-Grumayer","year":"1993","unstructured":"Panzer-Grumayer ER, Panzer S, Wolf M, Majdic O, Haas OA, Kersey JH (1993) Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation. J Immunol 151:92\u201399","journal-title":"J Immunol"},{"key":"21_CR78","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.V85.2.456.456","volume":"85","author":"RL Paterson","year":"1995","unstructured":"Paterson RL, Kelleher C, Amankonah TD, Streib JE, Xu JW, Jones JF, Gelfand EW (1995) Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Blood 85:456\u2013464","journal-title":"Blood"},{"key":"21_CR79","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SA Pileri","year":"2008","unstructured":"Pileri SA, Weisenburger DD, Sng I, Jaffe ES (2008) Peripheral T-cell lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. WHO Press, Lyon","edition":"4"},{"key":"21_CR80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","volume":"488","author":"TJ Pugh","year":"2012","unstructured":"Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, Ramos AH, Ross MG, Russ C, Shefler E, Sivachenko A, Sogoloff B, Stojanov P, Tamayo P, Mesirov JP, Amani V, Teider N, Sengupta S, Francois JP, Northcott PA, Taylor MD, Yu F, Crabtree GR, Kautzman AG, Gabriel SB, Getz G, Jager N, Jones DT, Lichter P, Pfister SM, Roberts TM, Meyerson M, Pomeroy SL, Cho YJ (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106\u2013110","journal-title":"Nature"},{"key":"21_CR81","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443.014k32_443_451","volume":"96","author":"L Quintanilla-Martinez","year":"2000","unstructured":"Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES (2000) Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96:443\u2013451","journal-title":"Blood"},{"key":"21_CR82","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"L Quintanilla-Martinez","year":"2008","unstructured":"Quintanilla-Martinez L, Kimura H, Jaffe ES (2008) EBV+ T-cell lymphoma of childhood. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. WHO Press, Lyon","edition":"4"},{"key":"21_CR83","unstructured":"Quintanilla-Martinez L, Ko YH, Kimura H, Jaffe ES (2017) EBV\u2013positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edn. WHO Press, Lyon"},{"key":"21_CR84","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","volume":"135","author":"DF Robbiani","year":"2008","unstructured":"Robbiani DF, Bothmer A, Callen E, Reina-San-Martin B, Dorsett Y, Difilippantonio S, Bolland DJ, Chen HT, Corcoran AE, Nussenzweig A, Nussenzweig MC (2008) AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations. Cell 135:1028\u20131038","journal-title":"Cell"},{"key":"21_CR85","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490:116\u2013120","journal-title":"Nature"},{"key":"21_CR86","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/jmv.20622","volume":"78","author":"Y Shibata","year":"2006","unstructured":"Shibata Y, Hoshino Y, Hara S, Yagasaki H, Kojima S, Nishiyama Y, Morishima T, Kimura H (2006) Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection. J Med Virol 78:770\u2013779","journal-title":"J Med Virol"},{"key":"21_CR87","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/JVI.68.9.6069-6073.1994","volume":"68","author":"N Shimizu","year":"1994","unstructured":"Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K (1994) Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt\u2019s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 68:6069\u20136073","journal-title":"J Virol"},{"key":"21_CR88","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.1038\/ncomms14257","volume":"8","author":"A Shumilov","year":"2017","unstructured":"Shumilov A, Tsai MH, Schlosser YT, Kratz AS, Bernhardt K, Fink S, Mizani T, Lin X, Jauch A, Mautner J, Kopp-Schneider A, Feederle R, Hoffmann I, Delecluse HJ (2017) Epstein-Barr virus particles induce centrosome amplification and chromosomal instability. Nat Commun 8:14257","journal-title":"Nat Commun"},{"key":"21_CR89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-102-1-7","volume":"102","author":"SE Straus","year":"1985","unstructured":"Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Davey R, Pearson G, Epstein J, Brus I, Et A (1985) Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 102:7\u201316","journal-title":"Ann Intern Med"},{"key":"21_CR90","first-page":"411","volume":"7","author":"KJ Sugimoto","year":"2014","unstructured":"Sugimoto KJ, Shimada A, Wakabayashi M, Imai H, Sekiguchi Y, Nakamura N, Sawada T, Ota Y, Takeuchi K, Ito Y, Kimura H, Komatsu N, Noguchi M (2014) A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma. Int J Clin Exp Pathol 7:411\u2013417","journal-title":"Int J Clin Exp Pathol"},{"key":"21_CR91","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1128\/JVI.00290-11","volume":"85","author":"R Suspene","year":"2011","unstructured":"Suspene R, Aynaud MM, Koch S, Pasdeloup D, Labetoulle M, Gaertner B, Vartanian JP, Meyerhans A, Wain-Hobson S (2011) Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J Virol 85:7594\u20137602","journal-title":"J Virol"},{"key":"21_CR92","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375\u20132390","journal-title":"Blood"},{"key":"21_CR93","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.4049\/jimmunol.170.12.5993","volume":"170","author":"J Tabiasco","year":"2003","unstructured":"Tabiasco J, Vercellone A, Meggetto F, Hudrisier D, Brousset P, Fournie JJ (2003) Acquisition of viral receptor by NK cells through immunological synapse. J Immunol 170:5993\u20135998","journal-title":"J Immunol"},{"key":"21_CR94","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2559.2011.03976.x","volume":"59","author":"E Takahashi","year":"2011","unstructured":"Takahashi E, Ohshima K, Kimura H, Hara K, Suzuki R, Kawa K, Eimoto T, Nakamura S (2011) Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)\/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders. Histopathology 59:660\u2013671","journal-title":"Histopathology"},{"key":"21_CR95","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1200\/JCO.2010.31.4096","volume":"29","author":"WL Teo","year":"2011","unstructured":"Teo WL, Tan SY (2011) Loss of Epstein-Barr virus-encoded RNA expression in cutaneous dissemination of natural killer\/T-cell lymphoma. J Clin Oncol 29:e342\u2013e343","journal-title":"J Clin Oncol"},{"key":"21_CR96","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328\u20131337","journal-title":"N Engl J Med"},{"key":"21_CR97","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood.V92.4.1374","volume":"92","author":"J Tsuchiyama","year":"1998","unstructured":"Tsuchiyama J, Yoshino T, Mori M, Kondoh E, Oka T, Akagi T, Hiraki A, Nakayama H, Shibuya A, Ma Y, Kawabata T, Okada S, Harada M (1998) Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma\/leukemia associated with Epstein-Barr virus infection. Blood 92:1374\u20131383","journal-title":"Blood"},{"key":"21_CR98","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2249.1999.00836.x","volume":"115","author":"I Tsuge","year":"1999","unstructured":"Tsuge I, Morishima T, Morita M, Kimura H, Kuzushima K, Matsuoka H (1999) Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line. Clin Exp Immunol 115:385\u2013392","journal-title":"Clin Exp Immunol"},{"key":"21_CR99","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm830","volume":"9","author":"SM Tugizov","year":"2003","unstructured":"Tugizov SM, Berline JW, Palefsky JM (2003) Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 9:307\u2013314","journal-title":"Nat Med"},{"key":"21_CR100","doi-asserted-by":"crossref","first-page":"20738","DOI":"10.1073\/pnas.1009635107","volume":"107","author":"N Prooyen Van","year":"2010","unstructured":"Van Prooyen N, Gold H, Andresen V, Schwartz O, Jones K, Ruscetti F, Lockett S, Gudla P, Venzon D, Franchini G (2010) Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proc Natl Acad Sci U S A 107:20738\u201320743","journal-title":"Proc Natl Acad Sci U S A"},{"key":"21_CR101","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","volume":"320","author":"LM Weiss","year":"1989","unstructured":"Weiss LM, Movahed LA, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in reed-Sternberg cells of Hodgkin\u2019s disease. N Engl J Med 320:502\u2013506","journal-title":"N Engl J Med"},{"key":"21_CR102","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ijc.22313","volume":"120","author":"JX Xu","year":"2007","unstructured":"Xu JX, Hoshida Y, Yang WI, Inohara H, Kubo T, Kim GE, Yoon JH, Kojya S, Bandoh N, Harabuchi Y, Tsutsumi K, Koizuka I, Jia XS, Kirihata M, Tsukuma H, Aozasa K (2007) Life-style and environmental factors in the development of nasal NK\/T-cell lymphoma: a case-control study in East Asia. Int J Cancer 120:406\u2013410","journal-title":"Int J Cancer"},{"key":"21_CR103","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/cas.12526","volume":"105","author":"M Yamaguchi","year":"2014","unstructured":"Yamaguchi M, Takata K, Yoshino T, Ishizuka N, Oguchi M, Kobayashi Y, Isobe Y, Ishizawa K, Kubota N, Itoh K, Usui N, Miyazaki K, Wasada I, Nakamura S, Matsuno Y, Oshimi K, Kinoshita T, Tsukasaki K, Tobinai K (2014) Prognostic biomarkers in patients with localized natural killer\/T-cell lymphoma treated with concurrent chemoradiotherapy. Cancer Sci 105:1435\u20131441","journal-title":"Cancer Sci"},{"key":"21_CR104","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1099\/0022-1317-82-10-2385","volume":"82","author":"M Yoshioka","year":"2001","unstructured":"Yoshioka M, Ishiguro N, Ishiko H, Ma X, Kikuta H, Kobayashi K (2001) Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection. J Gen Virol 82:2385\u20132392","journal-title":"J Gen Virol"},{"key":"21_CR105","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2141.2003.04359.x","volume":"121","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Nagata H, Ikeuchi T, Mukai H, Oyoshi MK, Demachi A, Morio T, Wakiguchi H, Kimura N, Shimizu N, Yamamoto K (2003) Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T\/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol 121:805\u2013814","journal-title":"Br J Haematol"},{"key":"21_CR106","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","volume":"228","author":"H Zur Hausen","year":"1970","unstructured":"Zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L (1970) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056\u20131058","journal-title":"Nature"}],"container-title":["Advances in Experimental Medicine and Biology","Human Herpesviruses"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-7230-7_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:20:39Z","timestamp":1693714839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-7230-7_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811072291","9789811072307"],"references-count":106,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-7230-7_21","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}